TABLE 5.
Histology result | HPV-Risk assay result for self-collected brush specimen | No. of clinician-obtained cervical scraping specimens with HPV-Risk assay resulta |
No. of self-collected brush specimens with GP5+/6+ PCR resultb |
|||||
---|---|---|---|---|---|---|---|---|
Invalid | Negative | Positive | Total | Negative | Positive | Total | ||
≤CIN1 | Negative | 5 | 31 | 4 | 40 | 36 | 4 | 40 |
Positive | 2 | 36 | 38 | 2 | 36 | 38 | ||
Total | 5 | 33 | 40 | 78 | 38 | 40 | 78 | |
CIN2+ | Negative | 2 | 1 | 3 | 2 | 1 | 3 | |
Positive | 2 | 29 | 31 | 1 | 30 | 31 | ||
Total | 4 | 30 | 34 | 3 | 31 | 34 | ||
Overall | Negative | 5 | 33 | 5 | 43 | 38 | 5 | 43 |
Positive | 4 | 65 | 69 | 3 | 66 | 69 | ||
Total | 5 | 37 | 70 | 112 | 41 | 71 | 112 |
Agreement between HPV-Risk assay results for self-collected and clinician-collected specimens was as follows: ≤CIN1, 92% (95% CI, 83 to 96%), 67/73 samples, kappa = 0.84; CIN2+, 91% (95% CI, 76 to 97%), 31/34 samples, kappa = 0.52; overall, 92% (95% CI, 85 to 96%), 98/107 samples, kappa = 0.82.
Agreement between HPV-Risk assay and GP5+/6+ PCR assay results was as follows: ≤CIN1, 92% (95% CI, 84 to 97%), 72/78 samples, kappa = 0.86; CIN2+, 94% (95% CI, 79 to 97%), 32/34 samples, kappa = 0.63; overall, 93% (95% CI, 86 to 96%), 104/112 samples, kappa = 0.86.